UPCOMING GRANTS

Cumming Global Centre for Pandemic Therapeutics Foundation Grants

Funding

Funding support is available up to $200,000 (Australian Dollars) per annum for a maximum of three years. 

Eligibility - Applicant

Round Two is open to investigators from organisations and institutions globally.  

Eligibility - Project

Work on all pathogens is welcome, providing the research is directly relevant to a pathogen of pandemic potential, noting that viruses are most likely to cause the next pandemic. High throughput screens for small molecules or rational drug design that are only focused on a single pathogen and not families of pathogens will not be funded. Clinical trials will also not be funded. 

Main focus areas will include:

• Development of platform technologies that will develop therapeutics for pathogens of pandemic potential at speed

• Fundamental virology, bacteriology or immunology that will identify novel targets for therapeutics for pathogens of pandemic potential

• Development of therapeutics that have activity across viral or relevant bacterial families e.g. therapeutics that have activity against all sarbecoviruses not just SARS-CoV-2

• Innovation in relation to enabling capabilities such as animal models, organoid systems, assay development, bioinformatics, genomics or biomarkers or other capabilities that can support therapeutic development 

How to apply

Applicants must complete and submit their expression of interest (EOI) form via the Smarty Grants online application form. These EOIs will be reviewed for alignment with the Cumming Global Centre mission, and for distribution across subject areas. A shortlist of applicants will then be invited to submit a full proposal.

Key Dates

• Expressions of Interest open: Wednesday 25 October 2023 

• Expressions of Interest close: midnight AEDT, Wednesday 29 November 2023 

• Invitation to submit full application issued:  Monday, 8 January 2024

• Full applications due: midnight AEDT, Monday, 18 March 2024

• Outcomes: June 2024